ID   TTBK2_HUMAN             Reviewed;        1244 AA.
AC   Q6IQ55; O94932; Q6ZN52; Q8IVV1;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   02-NOV-2010, entry version 74.
DE   RecName: Full=Tau-tubulin kinase 2;
DE            EC=2.7.11.1;
GN   Name=TTBK2; Synonyms=KIAA0847;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   PRO-8.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 600-1244 (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=99156230; PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   INVOLVEMENT IN SCA11.
RX   PubMed=18037885; DOI=10.1038/ng.2007.43;
RA   Houlden H., Johnson J., Gardner-Thorpe C., Lashley T., Hernandez D.,
RA   Worth P., Singleton A.B., Hilton D.A., Holton J., Revesz T.,
RA   Davis M.B., Giunti P., Wood N.W.;
RT   "Mutations in TTBK2, encoding a kinase implicated in tau
RT   phosphorylation, segregate with spinocerebellar ataxia type 11.";
RL   Nat. Genet. 39:1434-1436(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-786, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] PRO-8; GLN-120; ALA-313; MET-440;
RP   PRO-500; GLY-635; ILE-1062; MET-1084; ALA-1097; ARG-1122 AND THR-1241.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase which is able to phosphorylate
CC       tau on serines (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6IQ55-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6IQ55-2; Sequence=VSP_018272, VSP_018275;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=Q6IQ55-3; Sequence=VSP_018273, VSP_018274;
CC         Note=No experimental confirmation available;
CC   -!- DISEASE: Defects in TTBK2 are the cause of spinocerebellar ataxia
CC       type 11 (SCA11) [MIM:604432]. Spinocerebellar ataxia is a
CC       clinically and genetically heterogeneous group of cerebellar
CC       disorders. Patients show progressive incoordination of gait and
CC       often poor coordination of hands, speech and eye movements, due to
CC       degeneration of the cerebellum with variable involvement of the
CC       brainstem and spinal cord. SCA11 is an autosomal dominant
CC       cerebellar ataxia (ADCA). It is a relatively benign, late-onset,
CC       slowly progressive neurologic disorder.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/TTBK2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK131372; BAD18523.1; -; mRNA.
DR   EMBL; BC041876; AAH41876.1; -; mRNA.
DR   EMBL; BC071556; AAH71556.1; -; mRNA.
DR   EMBL; AB020654; BAA74870.1; -; mRNA.
DR   IPI; IPI00217145; -.
DR   IPI; IPI00743279; -.
DR   IPI; IPI00743694; -.
DR   RefSeq; NP_775771.3; -.
DR   UniGene; Hs.659846; -.
DR   UniGene; Hs.724640; -.
DR   ProteinModelPortal; Q6IQ55; -.
DR   SMR; Q6IQ55; 16-299.
DR   STRING; Q6IQ55; -.
DR   PRIDE; Q6IQ55; -.
DR   Ensembl; ENST00000267890; ENSP00000267890; ENSG00000128881.
DR   GeneID; 146057; -.
DR   KEGG; hsa:146057; -.
DR   UCSC; uc001zqo.1; human.
DR   UCSC; uc001zqp.2; human.
DR   UCSC; uc010bcy.1; human.
DR   CTD; 146057; -.
DR   GeneCards; GC15M043036; -.
DR   H-InvDB; HIX0012177; -.
DR   HGNC; HGNC:19141; TTBK2.
DR   HPA; HPA018113; -.
DR   MIM; 604432; phenotype.
DR   MIM; 611695; gene.
DR   Orphanet; 98767; Spinocerebellar ataxia type 11.
DR   PharmGKB; PA134913925; -.
DR   eggNOG; prNOG17213; -.
DR   HOVERGEN; HBG061812; -.
DR   OrthoDB; EOG9CJZ2M; -.
DR   PhylomeDB; Q6IQ55; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 85251; -.
DR   ArrayExpress; Q6IQ55; -.
DR   Bgee; Q6IQ55; -.
DR   CleanEx; HS_TTBK2; -.
DR   Genevestigator; Q6IQ55; -.
DR   GermOnline; ENSG00000128881; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008219; P:cell death; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Kinase;
KW   Neurodegeneration; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Spinocerebellar ataxia; Transferase.
FT   CHAIN         1   1244       Tau-tubulin kinase 2.
FT                                /FTId=PRO_0000234342.
FT   DOMAIN       21    284       Protein kinase.
FT   NP_BIND      27     35       ATP (By similarity).
FT   COMPBIAS    307    314       Poly-Thr.
FT   COMPBIAS   1150   1203       Ser-rich.
FT   ACT_SITE    141    141       Proton acceptor (By similarity).
FT   BINDING      50     50       ATP (By similarity).
FT   MOD_RES     786    786       Phosphoserine.
FT   VAR_SEQ       1     72       MSGGGEQLDILSVGILVKERWKVLRKIGGGGFGEIYDALDM
FT                                LTRENVALKVESAQQPKQVLKMEVAVLKKLQ -> MES
FT                                (in isoform 2).
FT                                /FTId=VSP_018272.
FT   VAR_SEQ     470    478       CLEKMQKDT -> WYKIVYFSF (in isoform 3).
FT                                /FTId=VSP_018273.
FT   VAR_SEQ     479   1244       Missing (in isoform 3).
FT                                /FTId=VSP_018274.
FT   VAR_SEQ    1233   1244       QGKSKPASKLSR -> PREE (in isoform 2).
FT                                /FTId=VSP_018275.
FT   VARIANT       8      8       L -> P (in dbSNP:rs6493068).
FT                                /FTId=VAR_041261.
FT   VARIANT     120    120       R -> Q (in dbSNP:rs35328266).
FT                                /FTId=VAR_041262.
FT   VARIANT     313    313       T -> A (in dbSNP:rs56017612).
FT                                /FTId=VAR_041263.
FT   VARIANT     440    440       V -> M (in dbSNP:rs56311523).
FT                                /FTId=VAR_041264.
FT   VARIANT     500    500       R -> P (in dbSNP:rs56039839).
FT                                /FTId=VAR_041265.
FT   VARIANT     635    635       D -> G (in a lung small cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041266.
FT   VARIANT    1062   1062       T -> I (in dbSNP:rs55833708).
FT                                /FTId=VAR_041267.
FT   VARIANT    1084   1084       T -> M (in dbSNP:rs34348991).
FT                                /FTId=VAR_041268.
FT   VARIANT    1097   1097       V -> A (in dbSNP:rs55796513).
FT                                /FTId=VAR_041269.
FT   VARIANT    1122   1122       P -> R (in dbSNP:rs56142516).
FT                                /FTId=VAR_041270.
FT   VARIANT    1241   1241       K -> T (in dbSNP:rs36104367).
FT                                /FTId=VAR_041271.
FT   CONFLICT    309    309       T -> I (in Ref. 1; BAD18523).
FT   CONFLICT    456    456       T -> A (in Ref. 1; BAD18523).
FT   CONFLICT    557    557       K -> N (in Ref. 1; BAD18523).
SQ   SEQUENCE   1244 AA;  137412 MW;  EAB8FC28370966DE CRC64;
     MSGGGEQLDI LSVGILVKER WKVLRKIGGG GFGEIYDALD MLTRENVALK VESAQQPKQV
     LKMEVAVLKK LQGKDHVCRF IGCGRNDRFN YVVMQLQGRN LADLRRSQSR GTFTISTTLR
     LGRQILESIE SIHSVGFLHR DIKPSNFAMG RFPSTCRKCY MLDFGLARQF TNSCGDVRPP
     RAVAGFRGTV RYASINAHRN REMGRHDDLW SLFYMLVEFV VGQLPWRKIK DKEQVGSIKE
     RYDHRLMLKH LPPEFSIFLD HISSLDYFTK PDYQLLTSVF DNSIKTFGVI ESDPFDWEKT
     GNDGSLTTTT TSTTPQLHTR LTPAAIGIAN ATPIPGDLLR ENTDEVFPDE QLSDGENGIP
     VGVSPDKLPG SLGHPRPQEK DVWEEMDANK NKIKLGICKA ATEEENSHGQ ANGLLNAPSL
     GSPIRVRSEI TQPDRDIPLV RKLRSIHSFE LEKRLTLEPK PDTDKFLETC LEKMQKDTSA
     GKESILPALL HKPCVPAVSR TDHIWHYDEE YLPDASKPAS ANTPEQADGG GSNGFIAVNL
     SSCKQEIDSK EWVIVDKEQD LQDFRTNEAV GHKTTGSPSD EEPEVLQVLE ASPQDEKLQL
     GPWAENDHLK KETSGVVLAL SAEGPPTAAS EQYTDRLELQ PGAASQFIAA TPTSLMEAQA
     EGPLTAITIP RPSVASTQST SGSFHCGQQP EKKDLQPMEP TVELYSPREN FSGLVVTEGE
     PPSGGSRTDL GLQIDHIGHD MLPNIRESNK SQDLGPKELP DHNRLVVREF ENLPGETEEK
     SILLESDNED EKLSRGQHCI EISSLPGDLV IVEKDHSATT EPLDVTKTQT FSVVPNQDKN
     NEIMKLLTVG TSEISSRDID PHVEGQIGQV AEMQKNKISK DDDIMSEDLP GHQGDLSTFL
     HQEGKREKIT PRNGELFHCV SENEHGAPTR KDMVRSSFVT RHSRIPVLAQ EIDSTLESSS
     PVSAKEKLLQ KKAYQPDLVK LLVEKRQFKS FLGDLSSASD KLLEEKLATV PAPFCEEEVL
     TPFSRLTVDS HLSRSAEDSF LSPIISQSRK SKIPRPVSWV NTDQVNSSTS SQFFPRPPPG
     KPPTRPGVEA RLRRYKVLGS SNSDSDLFSR LAQILQNGSQ KPRSTTQCKS PGSPHNPKTP
     PKSPVVPRRS PSASPRSSSL PRTSSSSPSR AGRPHHDQRS SSPHLGRSKS PPSHSGSSSS
     RRSCQQEHCK PSKNGLKGSG SLHHHSASTK TPQGKSKPAS KLSR
//
